학술논문

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12® Lactobacillus rhamnosus LGG® in colorectal cancer patients
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 2023, 13)
Subject
Language
English
ISSN
2234943X